MDR defined as
MDR in medical contexts often refers to Multidrug Resistance. That's a big one in pharmacology, especially in oncology and infectious diseases. For example, in cancer treatment, MDR is when tumor cells become resistant to multiple structurally and functionally unrelated drugs. Another possibility is Multidrug-Resistant Organisms in microbiology, like MDR TB or MDR bacteria. But since the question is about a definition, maybe it's the pharmacological aspect.
Wait, the question is asking for the definition of MDR. Let's check the correct answer provided. The user mentioned the correct answer is, say, option C. So I need to reverse-engineer the options. Let me think of possible distractors. For example, options might confuse MDR with other terms like MDR-TB, MDR in hepatology (like MDR1 gene), or other definitions.
So the core concept here is the pharmacological principle of multidrug resistance in cancer cells. The correct answer would define it as resistance to multiple drugs with different mechanisms. The incorrect options might incorrectly define it as resistance to one class, a specific drug, or another unrelated concept like MDR in microbiology.
For the explanation, I need to outline why MDR is defined as resistance to multiple drugs, mention the P-glycoprotein (MDR1 gene product) as a key mechanism, and contrast it with the other options which might refer to other types of resistance or specific examples. The clinical pearl should highlight the importance of recognizing MDR in cancer treatment and potential strategies to overcome it, like using P-glycoprotein inhibitors.
Now, structuring the sections as per the user's instructions. Make sure each part is concise and fits within the character limit. Check for key terms and ensure clarity. Avoid markdown except for bold labels. Let me draft each section step by step, ensuring all parts are covered accurately.
**Core Concept**
Multidrug resistance (MDR) refers to the phenomenon where tumor cells develop resistance to multiple chemically and structurally unrelated antineoplastic agents. This is a major challenge in cancer therapy, often mediated by overexpression of ATP-binding cassette (ABC) transporters like **P-glycoprotein (P-gp, ABCB1)**, which efflux drugs from cells, reducing intracellular concentrations.
**Why the Correct Answer is Right**
The correct definition of MDR is resistance to **multiple structurally unrelated drugs** due to mechanisms like P-gp overexpression, mutations in drug targets, or enhanced DNA repair. P-gp, encoded by the **MDR1 gene**, actively pumps out a wide range of substrates, including anthracyclines, taxanes, and vinca alkaloids. This cross-resistance reduces the efficacy of diverse chemotherapeutic agents, complicating treatment strategies.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect if it defines MDR as resistance to a single drug class (e.g., penicillins). MDR specifically involves cross-resistance across multiple unrelated drugs.